Skip to content Skip to a section
Theranos: after “paras 1”, what about “paras 2”?
Photo by Max Morse for TechCrunch TechCrunch · CC BY 2.0
→ 50 lookup decisions

Theranos: after “paras 1”, what about “paras 2”?

Before 2015, U.S. magazines and tech columns treated Holmes as a rare female billionaire founder in hardware-heavy biotech — a narrative the Journal’s investigation then dismantled in public.

At a glance

Theranos · paras 1Before 2015, U.S. magazines and tech columns treated Holmes as a rare female…
Theranos · paras 2The Wall Street Journal owned the first-mover account; Vanity Fair, the New…
Theranos · paras 3The 2021–2022 trials were covered as a Silicon Valley morality play: black…
Theranos · When did the public case break?The Wall Street Journal published John Carreyrou’s first major investigation…

The Wall Street Journal owned the first-mover account; Vanity Fair, the New York Times, and later Bad Blood (2018) extended it. English-language finance desks read the story as due-diligence failure among famous investors as much as a lab story.

Atlas Verification Checklist

0 / 4 verified

Check each criteria to confirm findings against the atlas verdict.

✓ All 4 points verified — Atlas verdict confirmed:

The Wall Street Journal owned the first-mover account; Vanity Fair, the New York Times, and later Bad Blood (2018) extended it. English-language finance desks read the story as due-diligence failure among famous investors as much as a lab story.

Theranos · paras 1

Before 2015, U.S. magazines and tech columns treated Holmes as a rare female billionaire founder in hardware-heavy biotech — a narrative the Journal’s investigation then dismantled in public.

Theranos · paras 2

The Wall Street Journal owned the first-mover account; Vanity Fair, the New York Times, and later Bad Blood (2018) extended it. English-language finance desks read the story as due-diligence failure among famous investors as much as a lab story.

Theranos · paras 3

The 2021–2022 trials were covered as a Silicon Valley morality play: black turtleneck, dropped voice, and a jury that distinguished investor counts from patient counts — a distinction the tabloid shorthand often drops. The company claimed its devices could run a broad menu of clinical laboratory tests from a finger-stick or other small sample, faster and cheaper than a conventional venous draw sent to a central lab.

Theranos · When did the public case break?

The Wall Street Journal published John Carreyrou’s first major investigation on 15 October 2015. CMS sanctions, SEC charges (2018), and criminal trials followed. On 3 January 2022 a Northern District of California jury convicted her of conspiracy to commit wire fraud and three counts of wire fraud involving investors. She was acquitted on several other counts, including patient-related wire-fraud counts.

This is a reading check for the atlas, not personal advice, a live price, or a booking. It does not replace the full topic page.

What is the next question after this?

The 2021–2022 trials were covered as a Silicon Valley morality play: black turtleneck, dropped voice, and a jury that distinguished investor counts from patient counts — a distinction the tabloid shorthand often drops. The company claimed its devices could run a broad menu of clinical laboratory tests from a finger-stick or other small sample, faster and cheaper than a conventional venous draw sent to a central lab.

Does this page rank people or nations?

This is a reading check for the atlas, not personal advice, a live price, or a booking. It does not replace the full topic page.

Where is the longer entry?

The Wall Street Journal published John Carreyrou’s first major investigation on 15 October 2015. CMS sanctions, SEC charges (2018), and criminal trials followed. On 3 January 2022 a Northern District of California jury convicted her of conspiracy to commit wire fraud and three counts of wire fraud involving investors. She was acquitted on several other counts, including patient-related wire-fraud counts.

Next question: Sinking of the Titanic · Open the topic: Theranos